A large collection of conserved eukaryotic peptidyl-prolyl cis-trans isomerases. Some members of this group are secreted (into the ER).. Localization: Cytoplasmic (by homology) / ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
GO:0005737 | cytoplasm | 2 | 3 |
GO:0005930 | axoneme | 2 | 1 |
Related structures:
AlphaFold database: A4H346
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 22 |
GO:0006807 | nitrogen compound metabolic process | 2 | 22 |
GO:0008152 | metabolic process | 1 | 22 |
GO:0018193 | peptidyl-amino acid modification | 5 | 22 |
GO:0018208 | peptidyl-proline modification | 6 | 22 |
GO:0019538 | protein metabolic process | 3 | 22 |
GO:0036211 | protein modification process | 4 | 22 |
GO:0043170 | macromolecule metabolic process | 3 | 22 |
GO:0043412 | macromolecule modification | 4 | 22 |
GO:0044238 | primary metabolic process | 2 | 22 |
GO:0071704 | organic substance metabolic process | 2 | 22 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 22 |
GO:0006457 | protein folding | 2 | 10 |
GO:0009987 | cellular process | 1 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 22 |
GO:0003824 | catalytic activity | 1 | 22 |
GO:0016853 | isomerase activity | 2 | 22 |
GO:0016859 | cis-trans isomerase activity | 3 | 22 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 22 |
GO:0005488 | binding | 1 | 2 |
GO:0016018 | cyclosporin A binding | 4 | 2 |
GO:0033218 | amide binding | 2 | 2 |
GO:0042277 | peptide binding | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 223 | 227 | PF00656 | 0.261 |
CLV_C14_Caspase3-7 | 50 | 54 | PF00656 | 0.443 |
CLV_NRD_NRD_1 | 284 | 286 | PF00675 | 0.257 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.398 |
CLV_PCSK_KEX2_1 | 284 | 286 | PF00082 | 0.257 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.471 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.324 |
CLV_Separin_Metazoa | 43 | 47 | PF03568 | 0.346 |
DEG_SPOP_SBC_1 | 273 | 277 | PF00917 | 0.207 |
DOC_MAPK_gen_1 | 146 | 155 | PF00069 | 0.337 |
DOC_MAPK_MEF2A_6 | 148 | 157 | PF00069 | 0.303 |
DOC_PP1_RVXF_1 | 162 | 168 | PF00149 | 0.312 |
DOC_PP1_RVXF_1 | 291 | 298 | PF00149 | 0.378 |
DOC_PP2B_LxvP_1 | 205 | 208 | PF13499 | 0.173 |
DOC_PP2B_LxvP_1 | 42 | 45 | PF13499 | 0.341 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.325 |
DOC_USP7_MATH_1 | 54 | 58 | PF00917 | 0.435 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.509 |
DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.447 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.259 |
DOC_WW_Pin1_4 | 317 | 322 | PF00397 | 0.276 |
LIG_14-3-3_CanoR_1 | 105 | 113 | PF00244 | 0.493 |
LIG_14-3-3_CanoR_1 | 186 | 191 | PF00244 | 0.415 |
LIG_14-3-3_CanoR_1 | 284 | 290 | PF00244 | 0.336 |
LIG_BIR_III_4 | 261 | 265 | PF00653 | 0.262 |
LIG_BRCT_BRCA1_1 | 276 | 280 | PF00533 | 0.459 |
LIG_FHA_1 | 253 | 259 | PF00498 | 0.390 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.194 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.488 |
LIG_FHA_2 | 221 | 227 | PF00498 | 0.416 |
LIG_FHA_2 | 326 | 332 | PF00498 | 0.349 |
LIG_LIR_Apic_2 | 253 | 259 | PF02991 | 0.294 |
LIG_LIR_Gen_1 | 168 | 176 | PF02991 | 0.327 |
LIG_LIR_Gen_1 | 53 | 62 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 168 | 173 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 200 | 205 | PF02991 | 0.173 |
LIG_LIR_Nem_3 | 218 | 224 | PF02991 | 0.264 |
LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.493 |
LIG_PDZ_Class_1 | 332 | 337 | PF00595 | 0.400 |
LIG_Pex14_1 | 166 | 170 | PF04695 | 0.378 |
LIG_REV1ctd_RIR_1 | 218 | 226 | PF16727 | 0.245 |
LIG_REV1ctd_RIR_1 | 46 | 56 | PF16727 | 0.287 |
LIG_SH2_CRK | 10 | 14 | PF00017 | 0.444 |
LIG_SH2_CRK | 170 | 174 | PF00017 | 0.285 |
LIG_SH2_CRK | 256 | 260 | PF00017 | 0.285 |
LIG_SH2_GRB2like | 27 | 30 | PF00017 | 0.371 |
LIG_SH2_NCK_1 | 170 | 174 | PF00017 | 0.261 |
LIG_SH2_SRC | 211 | 214 | PF00017 | 0.173 |
LIG_SH2_STAP1 | 170 | 174 | PF00017 | 0.262 |
LIG_SH2_STAP1 | 36 | 40 | PF00017 | 0.430 |
LIG_SH2_STAT3 | 131 | 134 | PF00017 | 0.332 |
LIG_SH2_STAT5 | 131 | 134 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.286 |
LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.173 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 281 | 284 | PF00017 | 0.262 |
LIG_SH2_STAT5 | 294 | 297 | PF00017 | 0.262 |
LIG_SUMO_SIM_par_1 | 38 | 43 | PF11976 | 0.269 |
LIG_TYR_ITSM | 6 | 13 | PF00017 | 0.428 |
LIG_WRC_WIRS_1 | 4 | 9 | PF05994 | 0.322 |
MOD_CDK_SPK_2 | 317 | 322 | PF00069 | 0.173 |
MOD_CK1_1 | 197 | 203 | PF00069 | 0.316 |
MOD_CK1_1 | 276 | 282 | PF00069 | 0.306 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.630 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.607 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.173 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.277 |
MOD_GlcNHglycan | 238 | 241 | PF01048 | 0.324 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.528 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.280 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.388 |
MOD_GSK3_1 | 272 | 279 | PF00069 | 0.193 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.376 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.542 |
MOD_N-GLC_1 | 317 | 322 | PF02516 | 0.193 |
MOD_N-GLC_1 | 69 | 74 | PF02516 | 0.503 |
MOD_N-GLC_2 | 180 | 182 | PF02516 | 0.329 |
MOD_NEK2_1 | 142 | 147 | PF00069 | 0.523 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.354 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.207 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.347 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.327 |
MOD_NEK2_2 | 242 | 247 | PF00069 | 0.350 |
MOD_PIKK_1 | 60 | 66 | PF00454 | 0.508 |
MOD_PKA_2 | 185 | 191 | PF00069 | 0.426 |
MOD_Plk_1 | 153 | 159 | PF00069 | 0.334 |
MOD_Plk_1 | 252 | 258 | PF00069 | 0.312 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.268 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.226 |
MOD_Plk_4 | 285 | 291 | PF00069 | 0.274 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.259 |
MOD_ProDKin_1 | 317 | 323 | PF00069 | 0.276 |
MOD_SUMO_for_1 | 321 | 324 | PF00179 | 0.185 |
TRG_DiLeu_BaEn_1 | 102 | 107 | PF01217 | 0.384 |
TRG_DiLeu_LyEn_5 | 102 | 107 | PF01217 | 0.350 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.433 |
TRG_ENDOCYTIC_2 | 150 | 153 | PF00928 | 0.268 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.262 |
TRG_ENDOCYTIC_2 | 294 | 297 | PF00928 | 0.340 |
TRG_ER_diArg_1 | 284 | 286 | PF00400 | 0.257 |
TRG_Pf-PMV_PEXEL_1 | 105 | 110 | PF00026 | 0.329 |
TRG_Pf-PMV_PEXEL_1 | 222 | 226 | PF00026 | 0.389 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IL84 | Leptomonas seymouri | 57% | 100% |
A0A0S4IKA5 | Bodo saltans | 36% | 100% |
A0A3Q8ICB3 | Leishmania donovani | 27% | 100% |
A0A3R7M7E5 | Trypanosoma rangeli | 44% | 100% |
A0A3S5H7U6 | Leishmania donovani | 36% | 100% |
A0A3S7X325 | Leishmania donovani | 26% | 100% |
A0A3S7X410 | Leishmania donovani | 35% | 100% |
A0A3S7XB52 | Leishmania donovani | 33% | 100% |
A0A451EJ79 | Leishmania donovani | 83% | 100% |
A4HCI8 | Leishmania braziliensis | 25% | 100% |
A4HHU7 | Leishmania braziliensis | 23% | 100% |
A4HIW9 | Leishmania braziliensis | 34% | 100% |
A4HRE3 | Leishmania infantum | 83% | 100% |
A4I004 | Leishmania infantum | 27% | 100% |
A4I4Z7 | Leishmania infantum | 26% | 100% |
A4I698 | Leishmania infantum | 35% | 100% |
A4I935 | Leishmania infantum | 36% | 100% |
A4IDA1 | Leishmania infantum | 33% | 100% |
C9ZQE6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
C9ZXF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AC11 | Leishmania major | 83% | 99% |
E9AJA8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |
E9AVX7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9B0C7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9B1F3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9B400 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
Q1RMP7 | Bos taurus | 29% | 100% |
Q4Q1A6 | Leishmania major | 33% | 100% |
Q4Q6Q9 | Leishmania major | 35% | 100% |
Q4Q7V7 | Leishmania major | 25% | 100% |
Q4QBK2 | Leishmania major | 27% | 100% |
V5B9Y6 | Trypanosoma cruzi | 43% | 100% |